You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 24, June 23, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis

M. T. Grattan, C. E. Moreno-Cabral, V. A. Starnes, P. E. Oyer, E. B. Stinson and N. E. Shumway
Department of Cardiovascular Surgery, Stanford University Medical Center, CA 94305.

We studied the effects of cytomegalovirus (CMV) infection on 301 cardiac transplant recipients who were treated during the cyclosporine era of immunosuppression (1980 to the present). These patients received varying combinations of cyclosporine, azathioprine, prednisone, rabbit antithymocyte globulin, and OKT3 as their immunosuppressive therapy. Two hundred ten patients were free of CMV infection (non-CMV group). During the same period CMV infection developed in 91 patients, as manifested by a fourfold IgG serologic titer rise, demonstration of CMV inclusion bodies in tissue, or positive cultures for the virus (CMV group). The rate of graft rejection was significantly higher in the CMV group. Graft atherosclerosis was significantly more severe in the CMV group as judged by angiographic criteria or by pathologic study. Patient survival rates were significantly lower in the CMV group. Death caused by graft atherosclerosis was significantly more common among patients in the CMV group. Finally, the graft loss rate (from either death or retransplantation for atherosclerosis) was significantly greater in the CMV group. These data demonstrate that CMV infection in cardiac transplant recipients is associated with more frequent rejection, graft atherosclerosis, and death.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective follow-up of primary CMV infections after 6 months of valganciclovir prophylaxis in renal transplant recipients
Helantera et al.
Nephrol Dial Transplant 2008;0:gfn558v1-gfn558.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing
Dumortier et al.
J. Virol. 2008;82:6524-6535.
ABSTRACT | FULL TEXT  

Endothelial Dysfunction and Cytomegalovirus Replication in Pediatric Heart Transplantation
Simmonds et al.
Circulation 2008;117:2657-2661.
ABSTRACT | FULL TEXT  

Shared care in paediatric heart transplantation
Simmonds and Burch
EDUCATION AND PRACTICE 2008;93:37-43.
FULL TEXT  

The Full-Length Protein Encoded by Human Cytomegalovirus Gene UL117 Is Required for the Proper Maturation of Viral Replication Compartments
Qian et al.
J. Virol. 2008;82:3452-3465.
ABSTRACT | FULL TEXT  

The First Year Post-Heart Transplantation: Use of Immunosuppressive Drugs and Early Complications
Sulemanjee et al.
J CARDIOVASC PHARMACOL THER 2008;13:13-31.
ABSTRACT  

Reactivation of {gamma}HV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin
Spiekerkoetter et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2008;294:L276-L289.
ABSTRACT | FULL TEXT  

Immunobiology of Heart and Heart-Lung Transplantation
Griffith et al.
Card Surg Adult 2008;3:1513-1538.
FULL TEXT  

Heart-Lung and Lung Transplantation
Sheikh et al.
Card Surg Adult 2008;3:1579-1608.
FULL TEXT  

Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in Children
Webber
Circulation 2007;115:1701-1702.
FULL TEXT  

Positive Pretransplantation Cytomegalovirus Serology Is a Risk Factor for Cardiac Allograft Vasculopathy in Children
Hussain et al.
Circulation 2007;115:1798-1805.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus UL38 Protein Blocks Apoptosis
Terhune et al.
J. Virol. 2007;81:3109-3123.
ABSTRACT | FULL TEXT  

Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells
Yang et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;291:H2334-H2343.
ABSTRACT | FULL TEXT  

Poorer outcomes for recipients of heart allografts from HCV-positive donors: opening the silos.
Qamar and Rubin
JAMA 2006;296:1900-1901.
FULL TEXT  

T-Cell Immunity to Subclinical Cytomegalovirus Infection Reduces Cardiac Allograft Disease
Tu et al.
Circulation 2006;114:1608-1615.
ABSTRACT | FULL TEXT  

Murine Cytomegalovirus Infection Markedly Reduces Serum MCP-1 Levels in MCP-1 Transgenic Mice.
Froberg et al.
Annals of Clinical & Laboratory Science 2006;36:179-184.
ABSTRACT | FULL TEXT  

Cytomegalovirus colitis--an unusual cause for diarrhoea in an elderly woman
Lockwood et al.
Age Ageing 2006;35:198-200.
ABSTRACT | FULL TEXT  

Innate Immune Signaling and Porphyromonas gingivalis-accelerated Atherosclerosis
Gibson et al.
J. Dent. Res. 2006;85:106-121.
ABSTRACT | FULL TEXT  

Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10)
Shen et al.
Cardiovasc Res 2006;69:502-511.
ABSTRACT | FULL TEXT  

HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF {beta}-receptor
Reinhardt et al.
Cardiovasc Res 2005;67:151-160.
ABSTRACT | FULL TEXT  

Persistent cytomegalovirus infection is associated with increased expression of TGF-{beta}1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts
Helantera et al.
Nephrol Dial Transplant 2005;20:790-796.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Infection of Endothelial Cells Triggers Platelet Adhesion and Aggregation
Rahbar and Soderberg-Naucler
J. Virol. 2005;79:2211-2220.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Induces Inhibition of Macrophage Differentiation by Binding to Human Aminopeptidase N/CD13
Gredmark et al.
J. Immunol. 2004;173:4897-4907.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Inhibits Cytokine-Induced Macrophage Differentiation
Gredmark et al.
J. Virol. 2004;78:10378-10389.
ABSTRACT | FULL TEXT  

Cytomegalovirus Infection in Heart Transplant Recipients Is Associated With Impaired Endothelial Function
Petrakopoulou et al.
Circulation 2004;110:II-207-II-212.
ABSTRACT | FULL TEXT  

Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts
Leis et al.
J. Gen. Virol. 2004;85:1995-2000.
ABSTRACT | FULL TEXT  

HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner
Smith et al.
J. Leukoc. Biol. 2004;76:65-76.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence
Smith et al.
J. Virol. 2004;78:4444-4453.
ABSTRACT | FULL TEXT  

CMV Escapes!
Froberg
Annals of Clinical & Laboratory Science 2004;34:123-130.
ABSTRACT | FULL TEXT  

Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis
Weis et al.
Circulation 2004;109:500-505.
ABSTRACT | FULL TEXT  

Enhanced Cytomegalovirus Infection in Atherosclerotic Human Blood Vessels
Nerheim et al.
Am. J. Pathol. 2004;164:589-600.
ABSTRACT | FULL TEXT  

Role of a Mutation in Human Cytomegalovirus Gene UL104 in Resistance to Benzimidazole Ribonucleosides
Komazin et al.
J. Virol. 2004;78:710-715.
ABSTRACT | FULL TEXT  

Heart Transplantation
Poston and Griffith
J Intensive Care Med 2004;19:3-12.
ABSTRACT  

Resistance of Human Cytomegalovirus to the Benzimidazole L-Ribonucleoside Maribavir Maps to UL27
Komazin et al.
J. Virol. 2003;77:11499-11506.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus Inhibits Differentiation of Monocytes into Dendritic Cells with the Consequence of Depressed Immunological Functions
Gredmark and Soderberg-Naucler
J. Virol. 2003;77:10943-10956.
ABSTRACT | FULL TEXT  

Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
Eisen et al.
NEJM 2003;349:847-858.
ABSTRACT | FULL TEXT  

Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy
Vassalli et al.
Eur Heart J 2003;24:1180-1188.
ABSTRACT | FULL TEXT  

Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation
Lin et al.
J. Clin. Pathol. 2003;56:429-432.
ABSTRACT | FULL TEXT  

Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase Pathway
Weis and Cooke
Arterioscler. Thromb. Vasc. Bio. 2003;23:567-575.
ABSTRACT | FULL TEXT  

Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site
Kronschnabl and Stamminger
J. Gen. Virol. 2003;84:61-73.
ABSTRACT | FULL TEXT  

Immunobiology of Heart and Heart-Lung Transplantation
Griffith and Poston
Card Surg Adult 2003;2:1403-1426.
FULL TEXT  

Heart Transplantation
Bethea et al.
Card Surg Adult 2003;2:1427-1460.
FULL TEXT  

Heart-Lung and Lung Transplantation
Balsam et al.
Card Surg Adult 2003;2:1461-1490.
FULL TEXT  

Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy
Zhang et al.
Cardiovasc Res 2003;57:147-157.
ABSTRACT | FULL TEXT  

Upregulation of CD40 Expression on Endothelial Cells Infected with Human Cytomegalovirus
Maisch et al.
J. Virol. 2002;76:12803-12812.
ABSTRACT | FULL TEXT  

Increased Tissue Factor Expression Predicts Development of Cardiac Allograft Vasculopathy
Yen et al.
Circulation 2002;106:1379-1383.
ABSTRACT | FULL TEXT  

Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome
Yamani et al.
J Am Coll Cardiol 2002;39:970-977.
ABSTRACT | FULL TEXT  

Inflammation in acute coronary syndromes
Mulvihill and Foley
Heart 2002;87:201-204.
ABSTRACT | FULL TEXT  

Phosphorylation of {beta}-D-Ribosylbenzimidazoles Is Not Required for Activity against Human Cytomegalovirus
Krosky et al.
Antimicrob. Agents Chemother. 2002;46:478-486.
ABSTRACT | FULL TEXT  

Prevention of Cytomegalovirus Infection-enhanced Experimental Obliterative Bronchiolitis by Antiviral Prophylaxis or Immunosuppression in Rat Tracheal Allografts
TIKKANEN et al.
Am. J. Respir. Crit. Care Med. 2001;164:672-679.
ABSTRACT | FULL TEXT  

Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study
Kapadia et al.
J Am Coll Cardiol 2001;38:206-213.
ABSTRACT | FULL TEXT  

Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response
Zhu et al.
Int Immunol 2001;13:785-790.
ABSTRACT | FULL TEXT  

Association of Viral Genome with Graft Loss in Children after Cardiac Transplantation
Shirali et al.
NEJM 2001;344:1498-1503.
ABSTRACT | FULL TEXT  

Viral Triggers of Cardiac-Allograft Dysfunction
Avery
NEJM 2001;344:1545-1547.
FULL TEXT  

Cytomegalovirus Seropositivity and Serum Total Cholesterol Levels in Young Patients
Froberg et al.
Annals of Clinical & Laboratory Science 2001;31:157-161.
ABSTRACT | FULL TEXT  

Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus
Ricotta et al.
Cardiovasc Res 2001;49:440-448.
ABSTRACT | FULL TEXT  

Direct Quantification of Human Cytomegalovirus Immediate-Early and Late mRNA Levels in Blood of Lung Transplant Recipients by Competitive Nucleic Acid Sequence-Based Amplification
Greijer et al.
J. Clin. Microbiol. 2001;39:251-259.
ABSTRACT | FULL TEXT  

Ongoing Viral Replication Is Required for Gammaherpesvirus 68-Induced Vascular Damage
Dal Canto et al.
J. Virol. 2000;74:11304-11310.
ABSTRACT | FULL TEXT  

Cardiac Transplant Vasculopathy
Aranda and Hill
Chest 2000;118:1792-1800.
ABSTRACT | FULL TEXT  

Host Response to Cytomegalovirus Infection as a Determinant of Susceptibility to Coronary Artery Disease : Sex-Based Differences in Inflammation and Type of Immune Response
Zhu et al.
Circulation 2000;102:2491-2496.
ABSTRACT | FULL TEXT  

Elevated Levels of Plasma C-Reactive Protein Are Associated With Decreased Graft Survival in Cardiac Transplant Recipients
Eisenberg et al.
Circulation 2000;102:2100-2104.
ABSTRACT | FULL TEXT  

Coronary Angioplasty and Stenting in Orthotopic Heart Transplants: A Fruitful Act or a Futile Attempt?
Sharifi et al.
ANGIOLOGY 2000;51:809-815.
ABSTRACT  

Microorganisms in the aetiology of atherosclerosis
Morre et al.
J. Clin. Pathol. 2000;53:647-654.
ABSTRACT | FULL TEXT  

Herpesvirus Infection Accelerates Atherosclerosis in the Apolipoprotein E-Deficient Mouse
Alber et al.
Circulation 2000;102:779-785.
ABSTRACT | FULL TEXT  

Cardiac-Specific Troponin I Levels and Risk of Coronary Artery Disease and Graft Failure Following Heart Transplantation
Labarrere et al.
JAMA 2000;284:457-464.
ABSTRACT | FULL TEXT  

Infection and Atherosclerosis : Potential Roles of Pathogen Burden and Molecular Mimicry
Epstein et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:1417-1420.
ABSTRACT | FULL TEXT  

Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease
Holvoet et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:698-702.
ABSTRACT | FULL TEXT  

Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
Kotenko et al.
Proc. Natl. Acad. Sci. USA 2000;97:1695-1700.
ABSTRACT | FULL TEXT  

New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients
Sia and Patel
Clin. Microbiol. Rev. 2000;13:83-121.
ABSTRACT | FULL TEXT  

Cytomegalovirus in the pathogenesis of atherosclerosis: The role of inflammation as reflected by elevated C-reactive protein levels
Zhu et al.
J Am Coll Cardiol 1999;34:1738-1743.
ABSTRACT | FULL TEXT  

Mononuclear Leukocytes Preferentially Bind via CD44 to Hyaluronan on Human Intestinal Mucosal Smooth Muscle Cells after Virus Infection or Treatment with Poly(I{middle dot}C)
de la Motte et al.
J. Biol. Chem. 1999;274:30747-30755.
ABSTRACT | FULL TEXT  

Allograft Vasculopathy : Diagnosing the Nemesis of Heart Transplantation
Young
Circulation 1999;100:458-460.
FULL TEXT  

Infection and Atherosclerosis : Emerging Mechanistic Paradigms
Epstein et al.
Circulation 1999;100 :e20-e28.
ABSTRACT | FULL TEXT  

Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis : A Post Hoc Analysis of a Randomized, Placebo-Controlled Study
Valantine et al.
Circulation 1999;100:61-66.
ABSTRACT | FULL TEXT  

THIRTY YEARS OF CARDIAC TRANSPLANTATION AT STANFORD UNIVERSITY
Robbins et al.
J. Thorac. Cardiovasc. Surg. 1999;117:939-951.
ABSTRACT | FULL TEXT  

Humoral Immune Response to Human Cytomegalovirus in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty
Tiran et al.
CVI 1999;6:45-49.
ABSTRACT | FULL TEXT  

Prospective Study of Herpes Simplex Virus, Cytomegalovirus, and the Risk of Future Myocardial Infarction and Stroke
Ridker et al.
Circulation 1998;98:2796-2799.
ABSTRACT | FULL TEXT  

Current Status of Cardiac Transplantation
Hunt
JAMA 1998;280:1692-1698.
ABSTRACT | FULL TEXT  

Interferon gamma  Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels
Presti et al.
J. Exp. Med. 1998;188:577-588.
ABSTRACT | FULL TEXT  

Intracellular Signaling by the Chemokine Receptor US28 during Human Cytomegalovirus Infection
Billstrom et al.
J. Virol. 1998;72:5535-5544.
ABSTRACT | FULL TEXT  

Infection in Organ-Transplant Recipients
Fishman and Rubin
NEJM 1998;338:1741-1751.
FULL TEXT  

Resistance of Human Cytomegalovirus to Benzimidazole Ribonucleosides Maps to Two Open Reading Frames: UL89 and UL56
Krosky et al.
J. Virol. 1998;72:4721-4728.
ABSTRACT | FULL TEXT  

Atherosclerosis in Marek's disease virus infected hypercholesterolemic roosters is reduced by HMGCoA reductase and ACE inhibitor therapy
Lucas et al.
Cardiovasc Res 1998;38:237-246.
ABSTRACT | FULL TEXT  

Herpesviruses in Atherosclerosis and Thrombosis : Etiologic Agents or Ubiquitous Bystanders?
Nicholson and Hajjar
Arterioscler. Thromb. Vasc. Bio. 1998;18:339-348.
ABSTRACT | FULL TEXT  

Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease
Holvoet et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:100-107.
ABSTRACT | FULL TEXT  

Roles of Infectious Agents in Atherosclerosis and Restenosis: An Assessment of the Evidence and Need for Future Research
Libby et al.
Circulation 1997;96:4095-4103.
FULL TEXT  

Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat
Persoons et al.
Cardiovasc Res 1997;36:282-288.
ABSTRACT | FULL TEXT  

Chlamydia Pneumoniae, Cytomegalovirus, and Herpes Simplex Virus in Atherosclerosis of the Carotid Artery
Chiu et al.
Circulation 1997;96:2144-2148.
ABSTRACT | FULL TEXT  

Cardiac Allograft Vasculopathy : A Review
Weis and von Scheidt
Circulation 1997;96:2069-2077.
ABSTRACT | FULL TEXT  

Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link?
Nieto et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1780-1785.
ABSTRACT | FULL TEXT  

Cytomegalovirus Infection–Enhanced Cardiac Allograft Vasculopathy Is Abolished by DHPG Prophylaxis in the Rat
Lemstrom et al.
Circulation 1997;95:2614-2616.
ABSTRACT | FULL TEXT  

Reduced Coronary Flow Reserve During Exercise in Cardiac Transplant Recipients
Vassalli et al.
Circulation 1997;95:607-613.
ABSTRACT | FULL TEXT  

Natural Course of Moderate Cardiac Allograft Rejection (International Society for Heart Transplantation Grade 2) Early and Late After Transplantation
Rocca et al.
Circulation 1996;94:1334-1338.
ABSTRACT | FULL TEXT  

Cohort Study of Cytomegalovirus Infection as a Risk Factor for Carotid Intimal-Medial Thickening, a Measure of Subclinical Atherosclerosis
Nieto et al.
Circulation 1996;94:922-927.
ABSTRACT | FULL TEXT  

Prognostic Importance of Intimal Thickness as Measured by Intracoronary Ultrasound After Cardiac Transplantation
Rickenbacher et al.
Circulation 1995;92:3445-3452.
ABSTRACT | FULL TEXT  

Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection
Lemstrom et al.
Circulation 1995;92:2594-2604.
ABSTRACT | FULL TEXT  

Recent Advances in Cardiac Transplantation
Valantine and Schroeder
NEJM 1995;333:660-662.
FULL TEXT  

Influence of Preexistent Donor Coronary Artery Disease on the Progression of Transplant Vasculopathy : An Intravascular Ultrasound Study
Botas et al.
Circulation 1995;92:1126-1132.
ABSTRACT | FULL TEXT  

Vascular Cell Adhesion Molecule–1 Is Induced on Vascular Endothelia and Medial Smooth Muscle Cells in Experimental Cardiac Allograft Vasculopathy
Ardehali et al.
Circulation 1995;92:450-456.
ABSTRACT | FULL TEXT  

Cardiac transplant coronary artery disease: A multivariable analysisof pretransplantation risk factors for disease development and morbid events
McGiffin et al.
J. Thorac. Cardiovasc. Surg. 1995;109:1081-1089.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.